'World first' trial in Cardiff for new treatment for Type 1 diabetes
- 90 views
- 7 times supported
- 15 comments
All comments
Go to the last comment
Joined in 2018
1,420 comments posted |
53 of their responses were helpful to members
Rewards
-
Good Advisor
-
Contributor
-
Messenger
-
Committed
-
Explorer
-
Evaluator
Joined in 2018
989 comments posted |
6 of their responses were helpful to members
Rewards
-
Good Advisor
-
Contributor
-
Committed
-
Explorer
-
Evaluator
-
Friend
Joined in 2017
38 comments posted |
Rewards
-
Good Advisor
-
Contributor
-
Messenger
-
Committed
-
Explorer
-
Newsfeeder
Joined in 2017
Joined in 2015
21 comments posted |
1 of their responses was helpful to members
Rewards
-
Good Advisor
-
Contributor
-
Committed
-
Explorer
-
Evaluator
Joined in 2017
38 comments posted |
Rewards
-
Good Advisor
-
Contributor
-
Messenger
-
Committed
-
Explorer
-
Newsfeeder
Joined in 2017
38 comments posted |
Rewards
-
Good Advisor
-
Contributor
-
Messenger
-
Committed
-
Explorer
-
Newsfeeder
Joined in 2018
1,420 comments posted |
53 of their responses were helpful to members
Rewards
-
Good Advisor
-
Contributor
-
Messenger
-
Committed
-
Explorer
-
Evaluator
JosephineO
Community managerGood advisor
JosephineO
Community manager
Last activity on 15/07/2024 at 09:21
Joined in 2018
989 comments posted | 11 in the Treatments for type 1 diabetes treatments group
6 of their responses were helpful to members
Rewards
Good Advisor
Contributor
Committed
Explorer
Evaluator
Friend
A 'ground-breaking' clinical trial has been launched in Cardiff to help prevent and manage Type 1 diabetes.
The Clinical Research Facility at Cardiff and Vale University Health Board has dosed the first patient in the world with the new investigational drug. It aims to help the regrowth of insulin making ‘beta’ cells of the pancreas, which are lost in patients living with the disease.
Type 1 diabetes is a serious, lifelong condition where blood glucose levels are too high because the body cannot make a hormone called insulin. Those with Type 1 diabetes are dependent on insulin but if this clinical trial works, the regrowth - or regeneration - of beta cells may mean those with Type 1 diabetes becoming far less dependent on insulin injections.
So far, the drug appears to have had no major side-effects, but it is too early to say if it has been effective. The Cardiff team is hoping to attract up to eight adult volunteers to take part in the clinical trial who have had diabetes for more than two years.
"Despite everything achieved in diabetes care, advances in prevention haven’t really occurred. More insulin-producing beta cells are needed for those with this form of diabetes and it is estimated that 90% of patients with Type 1 diabetes have less", added Dr Mohammad Alhadj Ali.
Would you be interesting in trialing this medication?